Busulfan (Bu) in Combination with Double Nucleoside Analogues Fludarabine (Flu) and Clofarabine (Clo) Plus Vorinostat As a Novel Reduced Toxicity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients (pts) with Acute Leukemia

Kebriaei Partow; Wei Wei; Thall Peter F.; Ledesma Celina; Valdez Benigno C.; Popat Uday R.; Olson Amanda L.; Alousi Amin M.; Oran Betul; Ahmed Sairah; Ciurea Stefan O.; Patel Krina; Shpall Elizabeth J.; Hosing Chitra; Qazilbash Muzaffar H.; Shah Nina; Marin David; Rezvani Katayoun; Nieto Yago; Champlin Richard E.; Andersson Borje S.

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Busulfan (Bu) in Combination with Double Nucleoside Analogues Fludarabine (Flu) and Clofarabine (Clo) Plus Vorinostat As a Novel Reduced Toxicity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients (pts) with Acute Leukemia

【24h】

Busulfan (Bu) in Combination with Double Nucleoside Analogues Fludarabine (Flu) and Clofarabine (Clo) Plus Vorinostat As a Novel Reduced Toxicity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients (pts) with Acute Leukemia

机译：白消安（Bu）与双核苷类似物氟达拉滨（Flu）和氯法拉滨（Clo）加上伏立诺他合作为急性白血病患者（pts）同种异体造血细胞移植（HCT）的新型毒性降低的条件疗法

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2016年第22期|共6页
作者
Kebriaei Partow; Wei Wei; Thall Peter F.; Ledesma Celina; Valdez Benigno C.; Popat Uday R.; Olson Amanda L.; Alousi Amin M.; Oran Betul; Ahmed Sairah; Ciurea Stefan O.; Patel Krina; Shpall Elizabeth J.; Hosing Chitra; Qazilbash Muzaffar H.; Shah Nina; Marin David; Rezvani Katayoun; Nieto Yago; Champlin Richard E.; Andersson Borje S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献

1. Busulfan (Bu) in Combination with Double Nucleoside Analogues Fludarabine (Flu) and Clofarabine (Clo) Plus Vorinostat As a Novel Reduced Toxicity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients (pts) with Acute Leukemia [J] . Kebriaei Partow, Wei Wei, Thall Peter F., Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：白消安（Bu）与双核苷类似物氟达拉滨（Flu）和氯法拉滨（Clo）加上伏立诺他合作为急性白血病患者（pts）同种异体造血细胞移植（HCT）的新型毒性降低的条件疗法
2. More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes Without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT) [J] . Jeremy Pappacena, Valkal Bhatt, Gunjan L. Shah, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：更加强烈的氟纳比林/母艇（Flu / Bu）调理方案导致类似的结果，而不是在接受同种异体造血细胞移植（Allo-Hct）的血糖胺/ Melphalan（Flu / Mel）时添加严重毒性
3. Total body irradiation plus fludarabine compared to busulfan plus fludarabine as "reduced-toxicity conditioning" for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT [J] . Giebel Sebastian, Labopin Myriam, Sobczyk-Kruszelnicka Malgorzata, Bone marrow transplantation . 2021,第2期

机译：与急性髓白血病患者进行的急性肌细胞移植治疗的急性肌细胞间移植患者，全体乳头甘露群岛的总体辐照加氟芳香胺为“减少毒性调理”：EBMT急性白血病工作组的研究
4. Intravenous Busulfan Reduces Toxicity Associated with Myeloablative Allogeneic Hematopoietic Transplantation in Patients with Myeloid Malignancies [C] . A. Shimoni, B. Bxelorai, I. Hardan, European Haematology Association . 2002

机译：静脉内的伯鲁兰减少骨髓恶性肿瘤患者患有髓鞘异产造血移植的毒性
5. Genetic Associations in Acute Leukemia Patients After Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation [D] . Rizvi, Abbas A. 2019

机译：匹配的无关供体同种异体造血干细胞移植后急性白血病患者的遗传协会。
6. Fludarabine and busulfan as a reduced-toxicity myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation for acute leukemia patients [O] . ZHIMING DAI, JIE LIU, WANG-GANG ZHANG, -1

机译：氟达拉滨和白消安在急性白血病患者异基因造血干细胞移植中作为毒性降低的清髓性调理方案
7. More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes Without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT) [O] . Jeremy Pappacena, Valkal Bhatt, Gunjan L. Shah, 2018

机译：更加强烈的氟纳比林/母艇（Flu / Bu）调理方案导致类似的结果，而不是在接受同种异体造血细胞移植（Allo-Hct）的血糖胺/ Melphalan（Flu / Mel）时添加严重毒性

Busulfan (Bu) in Combination with Double Nucleoside Analogues Fludarabine (Flu) and Clofarabine (Clo) Plus Vorinostat As a Novel Reduced Toxicity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients (pts) with Acute Leukemia

著录项

相似文献

相关主题

期刊订阅